Mr Mrs Miss Ms Dr Other

Dr
Romain
Bouchand

European Patent Attorney

Paris Office

Technology & Engineering

Telephone. +33(0) 1 72 35 58 73
Email. rbouchand@hgf.com
Vcard

Experience

Romain started his career in academia where he acquired a large amount of experience in the fields of optics, electronics and quantum technologies, with notable experiences in France, Sweden, Switzerland and Ireland.
In 2017, he obtained a PhD from Sorbonne University in Paris proving expertise in laser technologies and electronics. He then worked as a scientist in a competitive research group in EPFL in Switzerland where he lead various scientific projects through international collaborations focusing on Photonics and Quantum measurements.

He moved in to intellectual property in 2019, working for a large US firm where he specialised in IP for medical devices and quantum computing. In 2022, he joined a leading French firm while specialising in patents related to artificial intelligence, especially when applied to the automotive industry. He joined HGF in early 2025 and brings his expertise in physics and AI-powered inventions.

Specialisms

Services

Qualifications

Patent Attorney

Europe

DIPL.-ING

Institute of Optics - Paris-Saclay University

MSC

KTH Royal Institute of Technology

PHD

Sorbonne University - Paris Observatory

POSTGRADUATE DIPLOMA OR CERTIFICATE

CEIPI - University Diploma - Intellectual Property (Spec. Patents)

Publications

A Turning Point for AI Patent Eligibility?

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us